Mechanism of Huangqintang in Alleviating Side Effect of Chemotherapy for Endometrial Cancer Based on Network Pharmacology and Molecular Docking

Si-hui YANG; Ling ZHOU; Jing XIE; Huai-jun ZHOU

doi:10.13422/j.cnki.syfjx.20220315

您当前的位置：

首页 >

文章列表页 >

Mechanism of Huangqintang in Alleviating Side Effect of Chemotherapy for Endometrial Cancer Based on Network Pharmacology and Molecular Docking

更新时间：2022-02-15

- Mechanism of Huangqintang in Alleviating Side Effect of Chemotherapy for Endometrial Cancer Based on Network Pharmacology and Molecular Docking
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 28, Issue 6, Pages: 167-174(2022)
- 作者机构：
  
  1.南京中医药大学中西医结合鼓楼临床医学院，南京 210008
  2.南京大学医学院附属鼓楼医院妇产医学中心，南京 210008
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfjx.20220315
  CLC： R285;R289;R22;R2-031;R33
- Received：14 November 2021，
  
  Published Online：14 January 2022，
  
  Published：20 March 2022
- 稿件说明：
移动端阅览
杨思慧,周凌,谢景等.基于网络药理学及分子对接探讨黄芩汤减轻子宫内膜癌化疗不良反应的机制[J].中国实验方剂学杂志,2022,28(06):167-174.

YANG Si-hui,ZHOU Ling,XIE Jing,et al.Mechanism of Huangqintang in Alleviating Side Effect of Chemotherapy for Endometrial Cancer Based on Network Pharmacology and Molecular Docking[J].Chinese Journal of Experimental Traditional Medical Formulae,2022,28(06):167-174.
杨思慧,周凌,谢景等.基于网络药理学及分子对接探讨黄芩汤减轻子宫内膜癌化疗不良反应的机制[J].中国实验方剂学杂志,2022,28(06):167-174. DOI： 10.13422/j.cnki.syfjx.20220315.

YANG Si-hui,ZHOU Ling,XIE Jing,et al.Mechanism of Huangqintang in Alleviating Side Effect of Chemotherapy for Endometrial Cancer Based on Network Pharmacology and Molecular Docking[J].Chinese Journal of Experimental Traditional Medical Formulae,2022,28(06):167-174. DOI： 10.13422/j.cnki.syfjx.20220315.

摘要

目的

基于实验及网络药理学和分子对接技术探讨黄芩汤是否可联合卡铂用于子宫内膜癌化疗及其具体机制。

方法

构建裸鼠子宫内膜癌皮下移植瘤模型，当瘤体体积达100 mm

左右时，将24只裸鼠随机分为模型组、黄芩汤组（3.5 g·kg

-1

）、卡铂组（50 mg·kg

-1

）、联合组（黄芩汤3.5 g·kg

-1

+卡铂50 mg·kg

-1

），每组6只。模型组给予生理盐水200 μL灌胃，每日灌胃2次。每2日测量裸鼠皮下移植瘤的体积及裸鼠的体质量。给药20 d后取裸鼠血液做肾功能及血常规检测，并处死裸鼠取瘤称质量。结合实验结果，通过网络药理学预测黄芩汤联合卡铂可能的作用机制，并通过分子对接预测活性成分的结合部位。

结果

黄芩汤组、卡铂组、联合组抑瘤率分别为8.87%、50.33%（

0.05）、64.66%（

0.01）。与模型组比较，卡铂组裸鼠体质量、白细胞、红细胞、血红蛋白下降，肌酐及尿酸明显上升（

0.05）；与卡铂组比较，联合组裸鼠体质量、白细胞、血红蛋白明显上升（

0.05），肌酐及尿酸明显降低（

0.05）。网络药理学筛选得到黄芩汤与卡铂副作用相关的活性成分114个，作用靶点200个，涉及的核心基因主要是热休克蛋白90AA1（HSP90AA1）、转录因子c-Jun（JUN）、丝裂原活化蛋白激酶（MAPK）等，分子对接表明核心成分汉黄芩素、黄芩素、可与HSP90AA1形成稳定的蛋白复合体，是潜在的活性分子。京都基因与基因组百科全书（KEGG）富集分析表明其可能与调节肿瘤坏死因子（TNF）信号通路、白细胞介素-17（IL-17）信号通路、MAPK信号通路、Toll样受体（TLRs）信号通路相关。

结论

黄芩汤未明显增强卡铂抑制子宫内膜癌增殖的作用，但联合用药可缓解卡铂诱导的副作用，其机制可能与中药复杂的调控网络相关。

Abstract

Objective

To evaluate the utility and mechanism of Huangqintang combined with carboplatin in chemotherapy of endometrial cancer by experiments as well as network pharmacology and molecular docking.

Method

The xenograft model of endometrial carcinoma was induced in BALB/c nude mice. When the tumor volume reached about 100 mm

，24 nude mice were randomly assigned into a model group， a Huangqintang group （3.5 g·kg

-1

），a carboplatin group （50 mg·kg

-1

），and a combination group （3.5 g·kg

-1

Huangqintang + 50 mg·kg

-1

carboplatin）， with six mice in each group. The mice in the model group received 200 μL of normal saline by gavage， twice a day. The volume of the tumor and the body weight of the mice were measured every two days. After drug intervention for 20 days， the blood of the mice was collected for renal function and blood routine tests. Then the nude mice were euthanized and the tumor was weighted. In combination with the experimental results，the underlying mechanism of Huangqintang combined carboplatin was predicted through network pharmacology and the binding sites of active components were predicted by molecular docking.

Result

The tumor inhibition rates of the Huangqintang group，the carboplatin group， and the combination group were 8.87%，50.33% （

0.05），and 64.66% （

0.01），respectively. Compared with the results in the model group，the body weight，leukocyte，erythrocyte， and hemoglobin in the carboplatin group decreased，and creatinine and uric acid increased （

0.05）. Compared with the carboplatin group，the combination group showed increased body weight，leukocyte， and hemoglobin （

0.05），and decreased creatinine and uric acid （

0.05）. A total of 114 potential active components of Huangqintang involved 200 targets related to the side effects of carboplatin. The core genes involved were mainly heat shock protein 90AA1 （HSP90AA1），transcription factor c-Jun （JUN）， and mitogen-activated protein kinase （MAPK）. Molecular docking showed that baicalein and wogonin could form a stable protein complex with HSP90AA1， serving as potential active molecules. Kyoto Encyclopedia of Genes and Genomes （KEGG） analysis revealed that it might be related to the regulation of tumor necrosis factor（TNF） signaling pathway，interleukin（IL）-17 signaling pathway， MAPK signaling pathway， and toll-like receptor pathway.

Conclusion

Huangqintang has no obvious inhibitory effect on endometrial cancer，and the tumor suppression effect is not significantly enhanced after combination with carboplatin，but Huangqintang can alleviate carboplatin-induced side effects. The mechanism may be related to the complex network of Chinese medicine.

关键词

Keywords

references

SIEGEL R L ， MILLER K D ， FUCHS H E ， et al . Cancer statistics，2021 ［J］. CA Cancer J Clin ， 2021 ， 71 （ 1 ）： 7 - 33 .

WANG Z ， GUO E ， YANG B ， et al . Trends and age-period-cohort effects on mortality of the three major gynecologic cancers in China from 1990 to 2019： Cervical， ovarian and uterine cancer ［J］. Gynecol Oncol ， 2021 ， 163 （ 2 ）： 358 - 363 .

XU Y ， BURMEISTER C ， HANNA R K ， et al . Predictors of survival after recurrence in women with early-stage endometrial carcinoma ［J］. Int J Gynecol Cancer ， 2016 ， 26 （ 6 ）： 1137 - 1142 .

谢玲玲，林荣春，林仲秋 . 《2021 NCCN子宫肿瘤临床实践指南（第1版）》解读［J］. 中国实用妇科与产科杂志， 2021 ， 37 （ 1 ）： 75 - 81 .

程傲霜，李晶，林仲秋 . 《2020 ESGO-ESTRO-ESP子宫内膜癌患者管理指南》解读［J］. 中国实用妇科与产科杂志， 2021 ， 37 （ 3 ）： 336 - 341 .

BROOKS R A ， FLEMING G F ， LASTRA R R ， et al . Current recommendations and recent progress in endometrial cancer ［J］. CA Cancer J Clin ， 2019 ， 69 （ 4 ）： 258 - 279 .

金碧霞，孔为民 . 《国际妇产科联盟（FIGO）2018癌症报告：子宫内膜癌诊治指南》解读［J］. 中国临床医生杂志， 2019 ， 47 （ 10 ）： 1155 - 1158 .

李闪闪，魏丹丹，蒋士卿 . 基于藏象理论探讨化疗药的药物毒性［J］. 中国实验方剂学杂志， 2021 ， 27 （ 5 ）： 198 - 205 .

田明敏 . 《伤寒论》黄芩汤方证研究［D］. 南京：南京中医药大学， 2018 .

徐静波，瞿溢谦，叶海勇 . 黄芩汤橐龠探析［J］. 新中医， 2020 ， 52 （ 3 ）： 19 - 21 .

LAM W ， JIANG Z ， GUAN F ， et al . PHY906（KD018），an adjuvant based on a 1800-year-old Chinese medicine，enhanced the anti-tumor activity of Sorafenib by changing the tumor microenvironment ［J］. Sci Rep ， 2015 ， 30 （ 5 ）： 9384 .

LIU S H ， CHENG Y C . Old formula，new Rx： the journey of PHY906 as cancer adjuvant therapy ［J］. J Ethnopharmacol ， 2012 ， 140 （ 3 ）： 614 - 623 .

XU D ， HOU X ， WANG O ， et al . A four-component combination derived from Huang-Qin decoction significantly enhances anticancer activity of irinotecan ［J］. Chin J Nat Med ， 2021 ， 19 （ 5 ）： 364 - 375 .

DING L ， DING Y ， KONG X Y ， et al . Dysregulation of Krüppel-like factor 12 in the development of endometrial cancer ［J］. Gynecol Oncol ， 2019 ， 152 ： 177 - 184 ..

WANG Y ， GAO C ， ZHANG Y ， et al . Visfatin stimulates endometrial cancer cell proliferation via activation of PI3K/Akt and MAPK/ERK1/2 signalling pathways ［J］. Gynecol Oncol ， 2016 ， 143 （ 1 ）： 168 - 178 .

崔兴，孙小琪，郑伟，等 . 黄芩汤调控自噬干预小鼠肠道急性移植物抗宿主病的机制［J］. 中国组织工程研究， 2022 ， 26 （ 7 ）： 1057 - 1062 .

SCHRAUWEN S ， COENEGRACHTS L ， CATTANEO A ， et al . The antitumor effect of metformin with and without carboplatin on primary endometrioid endometrial carcinoma in vivo ［J］. Gynecol Oncol ， 2015 ， 138 （ 2 ）： 378 - 382 .

FAZI R ， TINTORI C ， BRAI A ， et al . Homology model-based virtual screening for the identification of human helicase DDX3 inhibitors ［J］. J Chem Inf Model ， 2015 ， 55 （ 11 ）： 2443 - 2454 .

YE M ， LIU S ， JIANG Z ， et al . Liquid chromatography/mass spectrometry analysis of PHY906，a Chinese medicine formulation for cancer therapy ［J］. Rapid Commun Mass Spectrom ， 2007 ， 21 （ 22 ）： 3593 - 3607 .

FRIESNER R A ， BANKS J L ， MURPHY R B ， et al . Glide： a new approach for rapid， accurate docking and scoring. 1. Method and assessment of docking accuracy ［J］. J Med Chem ， 2004 ， 47 （ 7 ）： 1739 - 1749 .

LI-WEBER M . New therapeutic aspects of flavones： The anticancer properties of Scutellaria and its main active constituents wogonin，baicalein and baicalin ［J］. Cancer Treat Rev ， 2009 ， 35 （ 1 ）： 57 - 68 .

朱亚南，杨七妹，张硕，等 . 黄芩苷与黄芩素药理作用及机制研究进展［J］. 时珍国医国药， 2020 ， 31 （ 4 ）： 921 - 925 .

肖炜明，卜平，龚卫娟 . 汉黄芩素抗肿瘤和免疫调节作用的研究进展［J］. 中国中药杂志， 2014 ， 39 （ 16 ）： 3004 - 3009 .

李彦萍，龚燚婷，王嘉馨，等 . 基于网络药理学的汉黄芩素抑制人结直肠癌细胞SW480增殖机制研究［J］. 中国中药杂志， 2020 ， 45 （ 8 ）： 1772 - 1778 .

O'NEILL S ， ROSS J A ， WIGMORE S J ， et al . The role of heat shock protein 90 in modulating ischemia-reperfusion injury in the kidney ［J］. Expert Opin Investig Drugs ， 2012 ， 21 （ 10 ）： 1535 - 1548 .

李润玖，李锐，张彧 . 热休克蛋白生物学功能及其在肾损伤中作用的研究进展［J］. 中国急救复苏与灾害医学杂志， 2008 ， 3 （ 2 ）： 121 - 125 .

伍培，赵建美 . AP-1的研究进展［J］. 南通大学学报：医学版， 2018 ， 38 （ 1 ）： 41 - 45 .

BRAICU C ， BUSE M ， BUSUIOC C ， et al . A comprehensive review on MAPK： A promising therapeutic target in cancer ［J］. Cancers ， 2019 ， 11 （ 10 ）： 1618 .

BJÖRN N ， BADAM T V S ， SPALINSKAS R ， et al . Whole-genome sequencing and gene network modules predict gemcitabine/carboplatin-induced myelosuppression in non-small cell lung cancer patients ［J］. NPJ Syst Biol Appl ， 2020 ， 6 （ 1 ）： 25 .

BJÖRN N ， JAKOBSEN I ， LOTFI K ， et al . Single-cell RNA sequencing of hematopoietic stem and progenitor cells treated with gemcitabine and carboplatin ［J］. Genes ， 2020 ， 11 （ 5 ）： 549 .

CHEN G ， LIU B ， LI H ， et al . Ethnicity-stratified analysis of the association between TNF- α genetic polymorphisms and acute kidney injury： A systematic review and Meta-analysis ［J］. Biomed Res Int ， 2020 ， doi： 10.1155/2020/5262351 http://dx.doi.org/10.1155/2020/5262351 .

VELDHOEN M . Interleukin 17 is a chief orchestrator of immunity ［J］. Nat Immunol ， 2017 ， 18 （ 6 ）： 612 - 621 .

YOU Z ， LIU S P ， DU J ， et al . Advancements in MAPK signaling pathways and MAPK-targeted therapies for ameloblastoma：A review ［J］. J Oral Pathol Med ， 2019 ， 48 （ 3 ）： 201 - 205 .

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Mahoniae Caulis Alkaloids Ameliorate Depression by Regulating Synaptic Plasticity via cAMP Pathway

Analysis of Potential Active Components and Molecular Mechanism of Baoxin Granules Regulating Ferroptosis in Treatment of Heart Failure

Effect and Mechanism of Angelicae Sinensis Radix-Polygonati Rhizoma Herb Pair in Treatment of Simple Obesity

Screening of Anti-breast Cancer Active Ingredients in Famous Classical Formula Yanghetang

Analysis on Pharmacodynamic Material Basis and Mechanism of Famous Classical Formula Renshen Wuweizi Tang in Treatment of Spleen and Lung Qi Deficiency Syndrome

Related Author

HE Junhui

JIA Chunlian

LAI Kedao

ZHOU Guili

ZHOU Rongfei

LI Yi

LI Dongmei

XIE Jiaxiu

Related Institution

Key Laboratory of Chemistry and Engineering of Forest Products， National Ethnic Affairs Commission， Guangxi Key Laboratory of Chemistry and Engineering of Forest Products/Guangxi Collaborative Innovation Center for Chemistry and Engineering of Forest Products， School of Chemistry and Chemical Engineering， Guangxi Minzu University

Guangxi Key Laboratory of Chinese Medicine Quality Standard， Guangxi Institute of Chinese Medicine and Pharmaceutical Science

Guangxi Medical University

State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs， Institute of Chinese Materia Medica， China Academy of Chinese Medical Sciences

Jiangxi Province Key Laboratory of Traditional Chinese Medicine（TCM） Pharmacology，Institute of TCM Health Industry，China Academy of Chinese Medical Sciences

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰